Substituted dihydroisoquinolinone compounds

Details Substituted dihydroisoquinolinone compounds Substituted dihydroisoquinolinone compounds

2005-10-11

2010-12-28

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S402000, C546S176000

Reexamination Certificate

active

07858641

ABSTRACT:
A variety of low molecular weight, guanidino-containing dihydroisoquinolinoines capable of acting as MC4-R agonists are provided. The compounds are useful in treating MC4-R mediated diseases. The compounds have the structure ID where the values of the variable are defined herein.

REFERENCES:
patent: 3177218 (1965-04-01), Brown
patent: 4128643 (1978-12-01), Merkel et al.
patent: 4211867 (1980-07-01), Rasmussen
patent: 4287341 (1981-09-01), Hess et al.
patent: 4496571 (1985-01-01), Yellin et al.
patent: 4626537 (1986-12-01), Dave et al.
patent: 4732916 (1988-03-01), Satoh et al.
patent: 4748165 (1988-05-01), Jones et al.
patent: 4874864 (1989-10-01), Schnur et al.
patent: 4948891 (1990-08-01), Schnur et al.
patent: 4948901 (1990-08-01), Schnur et al.
patent: 5086057 (1992-02-01), Sasagawa
patent: 5124328 (1992-06-01), Fisher et al.
patent: 5352704 (1994-10-01), Okuyama et al.
patent: 5362902 (1994-11-01), Barnish et al.
patent: 5547966 (1996-08-01), Atwal et al.
patent: 5637439 (1997-06-01), Kaneko et al.
patent: 5731408 (1998-03-01), Hadley et al.
patent: 5750573 (1998-05-01), Bianchi et al.
patent: 5885985 (1999-03-01), Macdonald et al.
patent: 5889025 (1999-03-01), Lohray et al.
patent: 5952381 (1999-09-01), Chen et al.
patent: 5962530 (1999-10-01), Engel et al.
patent: 6020349 (2000-02-01), Ankersen et al.
patent: 6030985 (2000-02-01), Gentile et al.
patent: 6054556 (2000-04-01), Huby et al.
patent: 6060589 (2000-05-01), Stark et al.
patent: 6127343 (2000-10-01), Andersen et al.
patent: 6180603 (2001-01-01), Frey, II
patent: 6225331 (2001-05-01), Cupps et al.
patent: 6313093 (2001-11-01), Frey, II
patent: 6391878 (2002-05-01), Cupps et al.
patent: 6716840 (2004-04-01), Chu et al.
patent: 6995269 (2006-02-01), Renhowe et al.
patent: 7034033 (2006-04-01), Boyce et al.
patent: 7368453 (2008-05-01), Boyce et al.
patent: 2002/0137939 (2002-09-01), Renhowe et al.
patent: 2002/0193595 (2002-12-01), Chu et al.
patent: 2003/0195187 (2003-10-01), Boyce et al.
patent: 2003/0207814 (2003-11-01), Boyce et al.
patent: 2003/0229025 (2003-12-01), Xiao et al.
patent: 2005/0059662 (2005-03-01), Boyce et al.
patent: 2006/0235019 (2006-10-01), Boyce et al.
patent: 31 08 322 (1981-12-01), None
patent: 0343894 (1989-11-01), None
patent: WO 96/24580 (1996-08-01), None
patent: WO 97/19911 (1997-06-01), None
patent: WO 97/41119 (1997-11-01), None
patent: WO 98/07420 (1998-02-01), None
patent: WO 99/64002 (1999-12-01), None
patent: WO 00/03973 (2000-01-01), None
patent: WO 00/17191 (2000-03-01), None
patent: WO 00/74679 (2000-12-01), None
patent: WO 01/04103 (2001-01-01), None
patent: WO 01/10842 (2001-02-01), None
patent: WO 01/55106 (2001-08-01), None
patent: WO 01/55107 (2001-08-01), None
patent: WO 01/55109 (2001-08-01), None
patent: WO 01/70337 (2001-09-01), None
patent: WO 01/70708 (2001-09-01), None
patent: WO 02/18327 (2002-03-01), None
patent: WO 02/062766 (2002-08-01), None
patent: WO 02/062776 (2002-08-01), None
patent: WO 02/081443 (2002-10-01), None
patent: WO 03/072056 (2003-09-01), None
patent: WO 03/099818 (2003-12-01), None
patent: WO 2005/051391 (2005-06-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, p. 205.
Dörwald, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
Vippagunta, et al. Advanced Drug Delivery Reviews, 48, 2001, p. 18.
Wolff, Manfred E., Ed. Burger's Medicinal Chemistry and Drug Discovery—Fifth Edition, New York: John Wiley & Sons, 1996, vol. 1, pp. 975-976.
Asagarasu, A. et al., “Synthesis of Dipeptide-Type Human Immunodeficiency Virus (HIV) Protease Inhibitors with a Binding Unit to GP120,”Chem. Pharm. Bull., vol. 46, No. 5, pp. 867-870, 1998, published by Pharmaceutical Society of Japan.
Banker, G.S., et al., “Modern Pharmaceutices, 3ed.,” Marcel Dekker, New York, 1996, pp. 451-596.
Cupps et al. (1998): STN International, CAPLUS database, Columbus (Ohio), Accession No. 1998: 388504.
Fehm, H. L. et al., “The Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin4−10Decreases Body Fat in Humans,”J. Clin. Endocrinology&Metabolism, vol. 86, No. 3, pp. 1144-1148, 2001, published by the Endocrine Society.
Fisher, et al., Int. J. Obes. Relat. Metab. Diord., 23, Suppl. I: 54-58, 1999.
Fong, T. M. et al., “ART (Protein Product of Agouti-Related Transcript) as an Antagonist of MC-3 and MC-4 Receptors,”Biochemical and Biophysical Res. Comm., vol. 237, pp. 629-631, 1997, published by Academic Press.
Goodfellow, et al., Curr. Top. Med. Chem. 3(8): 855-83, 2003.
Hadley, M. E. et al., “The Proopiomelanocortin System,”Ann. N. Y. Acad. Sci., 885:1, pp. 1-21, 1999.
Huszar, D. et al., “Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice,”Cell, vol. 88, pp. 131-141, Jan. 10, 1997, published by Cell Press.
Julia, M. et al., “Amidines and guanidines related to congocidine. III. Urea and trazene diamidines,”Bull. Soc. Chim. Fr., No. 1, pp. 376-382, 1968, published by Masson Editeur, Paris, France.
Kiefer, L.L. et al., “Mutations in the Carboxyl Terminus of the Agouti Protein Decrease Agouti Inhibition of Ligand Binding to the Melanocortin Receptors,”Biochemistry, vol. 36, pp. 2084-2090, 1997, published by American Chemical Society.
Lu, D. et al., “Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor,”Nature, vol. 371, pp. 799-802, Oct. 27, 1994.
Mountjoy, K. G. et al., “The Cloning of a Family of Genes That Encode the Melanocortin Receptors,”Science, vol. 257, pp. 1248-1251, Aug. 28, 1992.
Ollmann, M. M. et al., “Antagonism of Central melanocortin Receptors in Vitro and in Vivo by Agouti-Related Protein,”Science, vol. 278, pp. 135-138, Oct. 3, 1997.
Rossi, M. et al., “A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo,”Endocrinology, vol. 139, No. 10, pp. 4428-4431, 1998, published by The Endocrine Society.
Runti, C.; DeNardo, M.; Ulian F., “Fusaric Acid Derivatives and Analogues as Possible Antihypertensive Drugs,” II Farmaco Edizione Scientifica, vol. 36(4), pp. 260-268 (1981), published in Italy by the Society of Italian Pharmaceutical Science. This is an English-language document.
Smith, R. A. et al., “Discovery and Parallel Synthesis of a New Class of Cathepsin K Inhibitors,”Bioorganic&Medicinal Chemistry Letters, vol. 11, pp. 2951-2954, 2001, published by Elsevier Science Ltd.
Smolnik, R. et al., “Brain Potentials and Attention after Acute and Subchronic Intranasal Administration of ACTH 4-10 and Desacetyl-α-MSH in Humans,”Neuroendocrinology, vol. 70, pp. 63-72, 1999, published by S. Karger AG, Basel.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358-365.
International Preliminary Report on Patentability and Written Opinion for PCT/US2004/039020 dated May 22, 2006.
International Search Report for PCT/US2004/039020 dated Apr. 19, 2005.
Supplementary European Search Report for EP 04811698.2 dated Oct. 14, 2008.
Examination Report for EP 03738964.0 dated Aug. 5, 2008.
Examination Report for EP 03738964.0 dated Jan. 31, 2008.
International Preliminary Examination Report for PCT/US03/16442 dated Feb. 17, 2004.
International Search Report for PCT/US03/16442 dated Oct. 9, 2003.
Supplementary European Search Report for EP 03738964.0 dated Jul. 25, 2006.
Examination Report for EP 04776069.9 dated Mar. 25, 2008.
International Preliminary Report on Patentability for PCT/US2004/015959 dated Sep. 8, 2005.
International Search Report for PCT/US2004/015959 dated Oct. 22, 2004.

Affiliated with

Also associated with

Rating

Substituted dihydroisoquinolinone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted dihydroisoquinolinone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted dihydroisoquinolinone compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4223233